1. Home
  2. ASUR vs MDWD Comparison

ASUR vs MDWD Comparison

Compare ASUR & MDWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Asure Software Inc

ASUR

Asure Software Inc

HOLD

Current Price

$9.27

Market Cap

224.4M

Sector

Technology

ML Signal

HOLD

Logo MediWound Ltd.

MDWD

MediWound Ltd.

HOLD

Current Price

$16.52

Market Cap

214.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASUR
MDWD
Founded
1985
2000
Country
United States
Israel
Employees
N/A
N/A
Industry
EDP Services
Medicinal Chemicals and Botanical Products
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
224.4M
214.9M
IPO Year
1996
2013

Fundamental Metrics

Financial Performance
Metric
ASUR
MDWD
Price
$9.27
$16.52
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$14.33
$36.00
AVG Volume (30 Days)
68.6K
91.0K
Earning Date
04-30-2026
05-20-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$88,952,000.00
N/A
Revenue This Year
$16.33
$48.92
Revenue Next Year
$9.20
$35.04
P/E Ratio
N/A
N/A
Revenue Growth
63.39
N/A
52 Week Low
$6.80
$14.90
52 Week High
$11.47
$22.51

Technical Indicators

Market Signals
Indicator
ASUR
MDWD
Relative Strength Index (RSI) 59.65 45.32
Support Level $7.83 $14.90
Resistance Level $9.89 $18.49
Average True Range (ATR) 0.40 0.63
MACD 0.04 -0.07
Stochastic Oscillator 68.06 20.41

Price Performance

Historical Comparison
ASUR
MDWD

About ASUR Asure Software Inc

Asure Software Inc is a provider of cloud-based Human Capital Management (HCM) software solutions delivered as Software-as-a-Service (SaaS) to businesses of all sizes. It facilitates small and mid-sized businesses (SMBs) to develop their Human Capital to get to the next level, stay compliant, and allocate their time, money, and technology toward growth. The company's HCM suite, named AsureHCM, includes cloud-based Payroll and Tax, HR, a Time and Attendance software. Its HR services range from HR projects to outsourcing payroll to HR consulting services. The firm sells its products majorly in the United States.

About MDWD MediWound Ltd.

MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid, is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.

Share on Social Networks: